BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in BriaCell Therapeutics Corp. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q3 2022
- Shares held
- 2.66M
- +130.2K (+5.1%) vs. Q3 2022
- Total value
- $12.3M
- −$1.99M (−13.9%) vs. Q3 2022
- New holders
- 5
- 6 more added
- Sold out
- 5
- 4 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynwood Capital Management Inc. | 1,530,000 | $6.69M | 8.04% | +332,000+27.7% | Added |
| K.J. Harrison & Partners Inc | 427,583 | $2.52M | 0.49% | −52,255−10.9% | Reduced |
| Wasatch Advisors Inc | 406,610 | $1.78M | 0.01% | +52,866+14.9% | Added |
| Redmond Asset Management, LLC | 137,689 | $601.7K | 0.22% | 00.0% | Unchanged |
| Summit Trail Advisors, LLC | 35,000 | $152.9K | 0.01% | 00.0% | Unchanged |
| Simplex Trading, LLC | 28,896 | $126.0K | 0.01% | +11,576+66.8% | Added |
| Virtu Financial LLC | 20,263 | $89.0K | 0.01% | −28,084−58.1% | Reduced |
| Concord Wealth Partners | 17,775 | $77.7K | 0.02% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 13,773 | $60.2K | 0.01% | +13,773 | New |
| Natixis | 12,500 | $56.3K | 0.00% | +12,500 | New |
| Sabby Management, LLC | 11,905 | $52.0K | 0.14% | −82,100−87.3% | Reduced |
| Bank of Montreal | 10,500 | $49.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,924 | $17.1K | 0.00% | +947+31.8% | Added |
| Tower Research Capital LLC (TRC) | 3,560 | $16.0K | 0.00% | +1,369+62.5% | Added |
| National Bank of Canada | 2,500 | $10.8K | 0.00% | +2,500 | New |
| Advisory Services Network, LLC | 1,177 | $5.14K | 0.00% | +1,177 | New |
| Royal Bank of Canada | 177 | $1.00K | 0.00% | +170+2,428.6% | Added |
| Bank of America Corp | 112 | $490 | 0.00% | −388−77.6% | Reduced |
| GHP Investment Advisors, Inc. | 33 | $144 | 0.00% | 00.0% | Unchanged |
| Rosenberg Matthew Hamilton | 12 | $52 | 0.00% | +12 | New |
| Advisor Group Holdings, Inc. | 32 | $0 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −97,092−100.0% | Sold out |
| Apollon Wealth Management, LLC | 0 | $0 | 0.00% | −17,900−100.0% | Sold out |
| Bluefin Capital Management, LLC | 0 | $0 | 0.00% | −17,546−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −2,016−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,282−100.0% | Sold out |
| Covington Capital Management | – | – | – | – | Not filed |